EFFICACY AND TOLERABILITY OF AMLODIPINE/TELMISARTAN COMBINATION THERAPY IN HYPERTENSIVE PATIENTS WITH CARDIOVASCULAR RISK FACTORS

被引：0

|

作者：

不详

机构：

来源：

HEART | 2012年 / 98卷

关键词：

D O I：

10.1136/heartjnl-2012-302920j.59

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：E180 / E180

页数：1

相关论文

共 50 条

[21] Efficacy of Initiating Therapy with Amlodipine and Hydrochlorothiazide or Their Combination in Hypertensive Nigerians
Iyalomhe, Godfrey B. S.
Omogbai, Eric K. I.
Isah, Ambrose O.
Iyalomhe, Osigbemhe O. B.
Dada, Folorunso L.
Iyalomhe, Sarah I.
CLINICAL AND EXPERIMENTAL HYPERTENSION, 2013, 35 (08) : 620 - 627
[22] Consistent efficacy in both men and women of a fixed-dose valsartan plus hydrochlorothiazide combination therapy compared with amlodipine monotherapy in hypertensive patients with additional cardiovascular risk factors
Heintz, Daniela
Malacco, Ettore
Ruilope, Luis M.
Stolt, Pelle
Kandra, Albert
Brandao, Andraea
Khder, Yasser
JOURNAL OF HYPERTENSION, 2006, 24 : 205 - 205
[23] Consistent efficacy of a fixed-dose valsartan plus HCTZ combination therapy vs amlodipine in obese and non-obese hypertensive patients with additional cardiovascular risk factors
Brandao, A. A.
Heintz, D.
Ruilope, L. M.
Malacco, E.
Kandra, A.
Khder, Y.
JOURNAL OF HYPERTENSION, 2006, 24 : S165 - S165
[24] Telmisartan plus amlodipine single-pill combination for the management of hypertensive patients with a metabolic risk profile (added-risk patients)
Ley, Ludwin
Schumacher, Helmut
CURRENT MEDICAL RESEARCH AND OPINION, 2013, 29 (01) : 41 - 53
[25] TELMISARTAN PLUS AMLODIPINE COMBINATION FOR THE MANAGEMENT OF HYPERTENSIVE PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Bolieva, L.
Daurova, M.
Gavins, F.
Daurova, M.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2014, 115 : 46 - 46
[26] Effects of telmisartan/amlodipine combination compared to single monotherapies in hypertensive patients with metabolic syndrome
Jamol, Uzokov
Aniskhon, Alyavi
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 68 (16) : C137 - C137
[27] An update on telmisartan/hydrochlorothiazide combinations for the management of hypertensive patients with additional cardiovascular risk factors
Kjeldsen, Sverre
Mancia, Giuseppe
Schmieder, Roland
Mattheus, Michaela
Unger, Thomas
EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2013, 11 (06) : 673 - 682
[28] Consistent efficacy of valsartan plus hydrochlorothiazide combination therapy vs amlodipine monotherapy in hypertensive patients at additional cardiovascular risk with or without reduced renal function
Ruilope, Luis M.
Malacco, Ettore
Kandrai, Albert
Heintzi, Daniela
Brandao, Andraea
Stolt, Pelle
Khder, Yasser
JOURNAL OF HYPERTENSION, 2006, 24 : 206 - 207
[29] Antiproteinuric effect of telmisartan/amlodipine versus losartan/amlodipine combination in microalbuminuric hypertensive patients with type 2 diabetes
Fogari, Roberto
Derosa, Giuseppe
Preti, Paola
Mugellini, Amedeo
Salvadeo, Sibilla A.
Zoppi, Annalisa
Lazzari, Pierangelo
HYPERTENSION, 2008, 52 (04) : E85 - E85
[30] Long-term safety, tolerability and efficacy of combination therapy with aliskiren and amlodipine in patients with hypertension
Littlejohn, Thomas W., III
Trenkwalder, Peter
Hollanders, Geert
Zhao, Yanxing
Liao, Weichi
CURRENT MEDICAL RESEARCH AND OPINION, 2009, 25 (04) : 951 - 959

← 1 2 3 4 5 →